Trial Outcomes & Findings for Promoting Engagement and COVID-19 Testing for Health (NCT NCT06141850)

NCT ID: NCT06141850

Last Updated: 2026-02-23

Results Overview

The number of individuals who reported (1) having COVID or COVID-like symptoms and (2) taking a COVID-19 test in the past month as reported using survey data (baseline only) or the text-based COVID-19 reporting tool created for this study (weeks 4, 8, and 12).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

290 participants

Primary outcome timeframe

Baseline, Weeks 4, 8, and 12

Results posted on

2026-02-23

Participant Flow

Participant enrollment began December 6, 2023 and follow-up assessments for the primary outcome measure were completed by January 8, 2025. The final follow-up assessment occurred March 25, 2025.

Participant milestones

Participant milestones
Measure
Project PEACH2 Intervention
In addition to a text-based reporting tool for reporting coronavirus disease 2019 (COVID-19) testing, participants randomized to the Project PEACH2 intervention were sent weekly behavioral nudges via mobile phone text message to encourage adherence to COVID-19 testing and preventive behaviors. COVID-19 Test Reporting: Participants use a simple text-based data reporting tool which they are asked to use to report any COVID-19 testing during the 12-month long study. Personalized Nudges via Text Messaging: Weekly behavioral nudges via mobile phone text messages, personalized to participants' diabetes status, race/ethnicity, age group, sex, and/or vaccine/testing history, are sent in weeks 1-16 of the intervention to encourage adherence to COVID-19 testing and preventive behaviors as well as other behaviors important for diabetes management, prevention, or care.
Control Group
Participants randomized to the control group receive access to the text-based COVID-19 reporting tool and receive weekly texts on diabetes prevention, management or care. COVID-19 Test Reporting: Participants use a simple text-based data reporting tool which they are asked to use to report any COVID-19 testing during the 12-month long study. Non-personalized Nudges via Text Messaging: Weekly behavioral nudges via mobile phone text messages are sent in weeks 1-16 of the intervention sharing tips lifestyle behaviors important for diabetes management and prevention (e.g., exercise, eating a healthy diet, etc.).
Overall Study
STARTED
145
145
Overall Study
COMPLETED
132
136
Overall Study
NOT COMPLETED
13
9

Reasons for withdrawal

Reasons for withdrawal
Measure
Project PEACH2 Intervention
In addition to a text-based reporting tool for reporting coronavirus disease 2019 (COVID-19) testing, participants randomized to the Project PEACH2 intervention were sent weekly behavioral nudges via mobile phone text message to encourage adherence to COVID-19 testing and preventive behaviors. COVID-19 Test Reporting: Participants use a simple text-based data reporting tool which they are asked to use to report any COVID-19 testing during the 12-month long study. Personalized Nudges via Text Messaging: Weekly behavioral nudges via mobile phone text messages, personalized to participants' diabetes status, race/ethnicity, age group, sex, and/or vaccine/testing history, are sent in weeks 1-16 of the intervention to encourage adherence to COVID-19 testing and preventive behaviors as well as other behaviors important for diabetes management, prevention, or care.
Control Group
Participants randomized to the control group receive access to the text-based COVID-19 reporting tool and receive weekly texts on diabetes prevention, management or care. COVID-19 Test Reporting: Participants use a simple text-based data reporting tool which they are asked to use to report any COVID-19 testing during the 12-month long study. Non-personalized Nudges via Text Messaging: Weekly behavioral nudges via mobile phone text messages are sent in weeks 1-16 of the intervention sharing tips lifestyle behaviors important for diabetes management and prevention (e.g., exercise, eating a healthy diet, etc.).
Overall Study
Withdrawal by Subject
5
5
Overall Study
Participant did not formally withdraw but did fill out surveys
8
4

Baseline Characteristics

Promoting Engagement and COVID-19 Testing for Health

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Project PEACH2 Intervention
n=145 Participants
In addition to a text-based reporting tool for reporting COVID-19 testing, participants randomized to the Project PEACH2 intervention were sent weekly behavioral nudges via mobile phone text message to encourage adherence to COVID-19 testing and preventive behaviors.
Control Group
n=145 Participants
Participants randomized to the control group receive access to the text-based COVID-19 reporting tool and receive weekly texts on diabetes prevention, management or care.
Total
n=290 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=58 Participants
0 Participants
0 Participants
n=1 Participants
Age, Categorical
Between 18 and 65 years
127 Participants
n=58 Participants
132 Participants
259 Participants
n=1 Participants
Age, Categorical
>=65 years
18 Participants
n=58 Participants
13 Participants
31 Participants
n=1 Participants
Sex/Gender, Customized
Female
112 Participants
n=58 Participants
117 Participants
229 Participants
n=1 Participants
Sex/Gender, Customized
Male
30 Participants
n=58 Participants
26 Participants
56 Participants
n=1 Participants
Sex/Gender, Customized
Not reported
3 Participants
n=58 Participants
2 Participants
5 Participants
n=1 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants
n=58 Participants
14 Participants
19 Participants
n=1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
139 Participants
n=58 Participants
130 Participants
269 Participants
n=1 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
n=58 Participants
1 Participants
2 Participants
n=1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=58 Participants
1 Participants
1 Participants
n=1 Participants
Race (NIH/OMB)
Asian
12 Participants
n=58 Participants
8 Participants
20 Participants
n=1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
n=58 Participants
0 Participants
1 Participants
n=1 Participants
Race (NIH/OMB)
Black or African American
77 Participants
n=58 Participants
71 Participants
148 Participants
n=1 Participants
Race (NIH/OMB)
White
49 Participants
n=58 Participants
55 Participants
104 Participants
n=1 Participants
Race (NIH/OMB)
More than one race
4 Participants
n=58 Participants
3 Participants
7 Participants
n=1 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
n=58 Participants
7 Participants
9 Participants
n=1 Participants
Region of Enrollment
United States
145 Participants
n=58 Participants
145 Participants
290 Participants
n=1 Participants

PRIMARY outcome

Timeframe: Baseline, Weeks 4, 8, and 12

Population: The number of participants analyzed at each time point are participants reporting symptoms of COVID-19.

The number of individuals who reported (1) having COVID or COVID-like symptoms and (2) taking a COVID-19 test in the past month as reported using survey data (baseline only) or the text-based COVID-19 reporting tool created for this study (weeks 4, 8, and 12).

Outcome measures

Outcome measures
Measure
Project PEACH2 Intervention
n=137 Participants
In addition to a text-based reporting tool for reporting COVID-19 testing, participants randomized to the Project PEACH2 intervention were sent weekly behavioral nudges via mobile phone text message to encourage adherence to COVID-19 testing and preventive behaviors.
Control Group
n=145 Participants
Participants randomized to the control group receive access to the text-based COVID-19 reporting tool and receive weekly texts on diabetes prevention, management or care.
Number of Participants With Symptoms Who Use a COVID-19 Test
Week 8
6 Participants
15 Participants
Number of Participants With Symptoms Who Use a COVID-19 Test
Baseline (participant self-reported via survey)
16 Participants
17 Participants
Number of Participants With Symptoms Who Use a COVID-19 Test
Week 4
3 Participants
10 Participants
Number of Participants With Symptoms Who Use a COVID-19 Test
Week 12
9 Participants
12 Participants

SECONDARY outcome

Timeframe: Baseline, Week 16 (completion of intervention), and Month 12

Population: This analysis includes participants who completed the study survey at the indicated time points.

The percent of participants receiving a partial or full dose of an approved COVID-19 vaccination or vaccine booster/annual vaccine.

Outcome measures

Outcome measures
Measure
Project PEACH2 Intervention
n=145 Participants
In addition to a text-based reporting tool for reporting COVID-19 testing, participants randomized to the Project PEACH2 intervention were sent weekly behavioral nudges via mobile phone text message to encourage adherence to COVID-19 testing and preventive behaviors.
Control Group
n=145 Participants
Participants randomized to the control group receive access to the text-based COVID-19 reporting tool and receive weekly texts on diabetes prevention, management or care.
Percent of Participants Receiving COVID-19 Vaccination
Baseline
83.4 percent of participants
82.1 percent of participants
Percent of Participants Receiving COVID-19 Vaccination
Week 16
85.6 percent of participants
83.1 percent of participants
Percent of Participants Receiving COVID-19 Vaccination
Month 12
90.0 percent of participants
88.6 percent of participants

SECONDARY outcome

Timeframe: Baseline, Week 16 (completion of intervention), and Month 12

Population: This analysis includes participants who completed the study survey at the indicated time points.

The number of participants reporting adhering to COVID-19 prevention behaviors is assessed based on survey responses on questions about masking, social distancing, isolating/quarantining when needed, and testing with symptom onset.

Outcome measures

Outcome measures
Measure
Project PEACH2 Intervention
n=145 Participants
In addition to a text-based reporting tool for reporting COVID-19 testing, participants randomized to the Project PEACH2 intervention were sent weekly behavioral nudges via mobile phone text message to encourage adherence to COVID-19 testing and preventive behaviors.
Control Group
n=145 Participants
Participants randomized to the control group receive access to the text-based COVID-19 reporting tool and receive weekly texts on diabetes prevention, management or care.
Number of Participants Adhering to COVID-19 Prevention Behaviors
Month 12
20 Participants
19 Participants
Number of Participants Adhering to COVID-19 Prevention Behaviors
Baseline
78 Participants
102 Participants
Number of Participants Adhering to COVID-19 Prevention Behaviors
Week 16
44 Participants
49 Participants

Adverse Events

Project PEACH2 Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Mary Beth Weber, PhD, MPH

Emory University

Phone: 404-712-1902

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place